Optic Nerve Atrophy: Patient-reported outcomes
Patient-reported outcomes after stem cell therapy for Optic Nerve Atrophy, based on 169 patients in our follow-up registry.
Updated ·
Overall patient-reported outcomes
Physical condition
reported physical improvement
69%
N = 141
Quality of life
reported quality-of-life improvement
62%
N = 155
Treatment satisfaction
satisfied with the treatment outcome
60%
N = 166
Reported change vs. before treatment
Worse No change Small Moderate Significant
| Symptom | Reported change vs. before treatment | Reported improvement |
|---|---|---|
| Light perception | | 58% |
| Ability to see hand movement | | 57% |
| Pain in the eyes | | 54% |
| Visual field | | 52% |
| Blindness | | 52% |
| Vision in left eye | | 49% |
| Vision in right eye | | 49% |
| Nystagmus (uncontrolled eye movement) | | 46% |
| Strabismus (side glances) | | 46% |
| Colour vision | | 44% |
| Ability to see things at a close distance | | 43% |
| Ability to see things clearly | | 42% |
| Able to count fingers | | 41% |
| Ability to focus eyes quickly | | 40% |
| Droopy eye lids | | 39% |
| Night vision | | 39% |
| Ability to keep eyes focused for a long time | | 38% |
| Ability to see things at a far distance | | 35% |
About this data
Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.
